Schroder Investment Management Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.08B Sell
1,169,027
-778,671
-40% -$789M 0.88% 15
2025
Q4
$2.09B Buy
1,947,698
+82,222
+4% +$78.6M 1.59% 11
2025
Q3
$1.42B Sell
1,865,476
-47,982
-3% -$35.7M 1.11% 16
2025
Q2
$1.49B Buy
1,913,458
+177,127
+10% +$138M 1.26% 13
2025
Q1
$1.43B Buy
1,736,331
+49,749
+3% +$41.4M 1.45% 9
2024
Q4
$1.3B Buy
1,686,582
+5,369
+0.3% +$4.45M 1.25% 13
2024
Q3
$1.49B Sell
1,681,213
-152,736
-8% -$137M 1.53% 9
2024
Q2
$1.66B Sell
1,833,949
-284,014
-13% -$227M 1.83% 7
2024
Q1
$1.65B Sell
2,117,963
-66,775
-3% -$47.5M 1.94% 7
2023
Q4
$1.27B Sell
2,184,738
-115,293
-5% -$67.3M 1.65% 8
2023
Q3
$1.24B Sell
2,300,031
-105,480
-4% -$54.4M 1.84% 7
2023
Q2
$1.13B Buy
2,405,511
+87,902
+4% +$36.9M 1.62% 8
2023
Q1
$796M Buy
2,317,609
+38,883
+2% +$13.1M 1.18% 11
2022
Q4
$834M Sell
2,278,726
-100,524
-4% -$35.6M 1.32% 9
2022
Q3
$769M Buy
2,379,250
+512,160
+27% +$162M 1.27% 9
2022
Q2
$603M Sell
1,867,090
-128,595
-6% -$38.6M 0.92% 17
2022
Q1
$579M Buy
1,995,685
+12,081
+0.6% +$3.11M 0.76% 25
2021
Q4
$548M Buy
1,983,604
+298,659
+18% +$75.7M 0.72% 25
2021
Q3
$389M Sell
1,684,945
-271,352
-14% -$67M 0.6% 27
2021
Q2
$449M Buy
1,956,297
+131,922
+7% +$26.5M 0.56% 31
2021
Q1
$341M Sell
1,824,375
-369,652
-17% -$72.3M 0.44% 42
2020
Q4
$370M Buy
2,194,027
+291,000
+15% +$43.4M 0.52% 37
2020
Q3
$276M Buy
1,903,027
+204,880
+12% +$31.7M 0.44% 43
2020
Q2
$279M Sell
1,698,147
-177,089
-9% -$27.2M 0.51% 36
2020
Q1
$266M Sell
1,875,236
-95,167
-5% -$13.1M 0.57% 33
2019
Q4
$259M Buy
1,970,403
+30,174
+2% +$3.5M 0.42% 49
2019
Q3
$218M Buy
1,940,229
+158,771
+9% +$17.7M 0.38% 54
2019
Q2
$197M Sell
1,781,458
-1,493,116
-46% -$176M 0.36% 62
2019
Q1
$425M Sell
3,274,574
-338,832
-9% -$41.2M 0.76% 23
2018
Q4
$418K Sell
3,613,406
-85,776
-2% -$9.58M 0.76% 20
2018
Q3
$397M Sell
3,699,182
-712,772
-16% -$71.3M 0.68% 24
2018
Q2
$377M Sell
4,411,954
-277,269
-6% -$22.8M 0.66% 22
2018
Q1
$363M Buy
4,689,223
+2,388,548
+104% +$192M 0.63% 22
2017
Q4
$194M Buy
2,300,675
+1,031,859
+81% +$87.8M 0.32% 66
2017
Q3
$108M Buy
1,268,816
+250,989
+25% +$20.6M 0.19% 128
2017
Q2
$84.2M Sell
1,017,827
-22,051
-2% -$1.8M 0.15% 174
2017
Q1
$88.1M Sell
1,039,878
-93,860
-8% -$7.52M 0.16% 174
2016
Q4
$83.4M Buy
1,133,738
+286,071
+34% +$21.3M 0.16% 169
2016
Q3
$68M Buy
847,667
+390,273
+85% +$31.2M 0.13% 195
2016
Q2
$36M Sell
457,394
-24,061
-5% -$1.81M 0.07% 338
2016
Q1
$34.6M Sell
481,455
-115,370
-19% -$8.73M 0.07% 326
2015
Q4
$50.3M Sell
596,825
-487,174
-45% -$40.4M 0.1% 241
2015
Q3
$90.7M Sell
1,083,999
-574,566
-35% -$48.5M 0.19% 136
2015
Q2
$139M Sell
1,658,565
-716,576
-30% -$54.6M 0.27% 94
2015
Q1
$175M Sell
2,375,141
-1,541,406
-39% -$110M 0.34% 73
2014
Q4
$270M Sell
3,916,547
-1,709,372
-30% -$115M 0.53% 34
2014
Q3
$365M Sell
5,625,919
-1,081,650
-16% -$68.5M 0.49% 40
2014
Q2
$417M Buy
6,707,569
+453,071
+7% +$27M 0.52% 33
2014
Q1
$368M Sell
6,254,498
-239,688
-4% -$13.4M 0.41% 51
2013
Q4
$331M Buy
6,494,186
+101,786
+2% +$5.1M 0.41% 44
2013
Q3
$322M Buy
6,392,400
+433,360
+7% +$22.7M 0.78% 16
2013
Q2
$293M Buy
+5,959,040
New +$324M 0.77% 14

Other funds holding LLY

Schroder Investment Management Group's LLY Position: Q1 2026 in Review

Schroder Investment Management Group reduced its Eli Lilly (LLY) stake by 40% in Q1 2026, selling an estimated $789M and leaving 1,169,027 shares worth $1.08B. The position accounts for 0.88% of the portfolio, ranked #15.

Schroder Investment Management Group first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.09B in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Schroder Investment Management Group held 1,169,027 shares of Eli Lilly worth $1.08B as of Q1 2026.
  • Schroder Investment Management Group sold 778,671 Eli Lilly shares in Q1 2026, an estimated $789M.
  • Eli Lilly made up 0.88% of Schroder Investment Management Group's portfolio in Q1 2026, its #15 holding.
  • Schroder Investment Management Group first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Schroder Investment Management Group's Eli Lilly position peaked at $2.09B in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Schroder Investment Management Group's 13F filing for Q1 2026, filed 14 May 2026.